The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 20, 2019

Filed:

Oct. 14, 2016
Applicant:

Attenuex Technologies, Inc., Newton, MA (US);

Inventors:

Ernest G. Schutt, San Diego, CA (US);

Kevin G. Connors, Wellesley, MA (US);

John Gillespie, Jr., Dover, MA (US);

Peter Dayton, Brookline, MA (US);

Assignee:

SOLACE THERAPEUTICS, INC., Framingham, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 1/307 (2006.01); A61B 5/20 (2006.01); A61B 17/04 (2006.01); A61B 17/221 (2006.01); A61B 17/66 (2006.01); A61B 17/70 (2006.01); A61B 17/82 (2006.01); A61F 2/00 (2006.01); A61F 2/12 (2006.01); A61F 2/24 (2006.01); A61F 2/26 (2006.01); A61M 25/00 (2006.01); A61M 29/02 (2006.01); A61B 17/00 (2006.01); A61B 17/34 (2006.01); A61M 25/10 (2013.01); A61B 90/00 (2016.01); A61B 17/3205 (2006.01); A61B 18/14 (2006.01); A61B 17/22 (2006.01); A61F 2/04 (2013.01); A61F 2/10 (2006.01); A61F 5/00 (2006.01); A61F 13/20 (2006.01); A61F 13/26 (2006.01); A61F 2/30 (2006.01); A61M 25/04 (2006.01); A61F 9/007 (2006.01);
U.S. Cl.
CPC ...
A61B 1/307 (2013.01); A61B 5/205 (2013.01); A61B 17/00234 (2013.01); A61B 17/0401 (2013.01); A61B 17/221 (2013.01); A61B 17/3468 (2013.01); A61B 17/66 (2013.01); A61B 17/70 (2013.01); A61B 17/7065 (2013.01); A61B 17/82 (2013.01); A61B 90/02 (2016.02); A61F 2/004 (2013.01); A61F 2/0027 (2013.01); A61F 2/12 (2013.01); A61F 2/2481 (2013.01); A61F 2/26 (2013.01); A61M 25/00 (2013.01); A61M 25/10 (2013.01); A61M 29/02 (2013.01); A61B 17/32056 (2013.01); A61B 17/3478 (2013.01); A61B 17/7098 (2013.01); A61B 18/1442 (2013.01); A61B 2017/00539 (2013.01); A61B 2017/00557 (2013.01); A61B 2017/00858 (2013.01); A61B 2017/0435 (2013.01); A61B 2017/2215 (2013.01); A61B 2017/22035 (2013.01); A61B 2017/22062 (2013.01); A61F 2/0059 (2013.01); A61F 2/042 (2013.01); A61F 2/10 (2013.01); A61F 5/0013 (2013.01); A61F 9/00781 (2013.01); A61F 13/20 (2013.01); A61F 13/26 (2013.01); A61F 2002/3071 (2013.01); A61F 2002/30617 (2013.01); A61F 2250/0059 (2013.01); A61F 2250/0067 (2013.01); A61F 2250/0068 (2013.01); A61F 2250/0085 (2013.01); A61F 2250/0097 (2013.01); A61M 25/04 (2013.01); A61M 25/1002 (2013.01); A61M 2025/0076 (2013.01); A61M 2025/1054 (2013.01); A61M 2210/1078 (2013.01); A61M 2210/1085 (2013.01);
Abstract

An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.


Find Patent Forward Citations

Loading…